To assess which patients respond best following cytoreductive nephrectomy for renal cell carcinoma (RCC) with sarcomatoid dedifferentiation (sRCC) and whether outcomes are improving over time.
We identified 562 patients with metastatic RCC treated between 1989-2018 with cytoreductive nephrectomy.